AGIO vs LMT · rev $65.5M vs P/E 20, rev $20.06B
Agios Pharm (AGIO) versus Lockheed Martin Corporation (LMT) — a side-by-side from cached financials, not a winner call.
Agios Pharm (AGIO) is a biotechnology company listed on US.
Lockheed Martin Corporation (LMT) is a aerospace & defense company listed on US. It is led by Jim Taiclet.
Latest reported AGIO revenue for 2026-06-30 was $65.5M. Net income was -$199.8M. AGIO currently screens at market cap $1.68B.
Latest reported LMT revenue for 2026-06-28 was $20.06B. Net income was $1.84B. Revenue was up 11.3% from 2026-03-29 to 2026-06-28. LMT currently screens at market cap $108.37B and trailing P/E 19.9.
AGIO currently screens at market cap $1.68B. LMT currently screens at market cap $108.37B and trailing P/E 19.9.
Not investment advice. Open the AGIO and LMT stock pages for the full models.
Not investment advice.